OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies
Anna Linehan, Mary O’Reilly, Ray McDermott, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 13
Anna Linehan, Mary O’Reilly, Ray McDermott, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 13
Showing 13 citing articles:
Integrating CRISPR Technology with Key Genetic Markers in Pancreatic Cancer: A New Frontier in Targeted Therapies
Dimitrios Stefanoudakis
SynBio (2025) Vol. 3, Iss. 1, pp. 1-1
Open Access
Dimitrios Stefanoudakis
SynBio (2025) Vol. 3, Iss. 1, pp. 1-1
Open Access
Decoding pancreatic cancer: key risk factors across genetics and lifestyle
Rohit Sharma, Rashmi Ghosh, Sourabh Kumar, et al.
Expert Review of Molecular Diagnostics (2025), pp. 1-5
Closed Access
Rohit Sharma, Rashmi Ghosh, Sourabh Kumar, et al.
Expert Review of Molecular Diagnostics (2025), pp. 1-5
Closed Access
Insights into curcumin’s anticancer activity in pancreatic ductal adenocarcinoma: Experimental and computational evidence targeting HRAS, CCND1, EGFR and AKT1
Jun‐Feng Cao, Xiao Zhang, Qingjie Xia, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108264-108264
Closed Access
Jun‐Feng Cao, Xiao Zhang, Qingjie Xia, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108264-108264
Closed Access
Moving from the background towards the spotlight: A critical review of radiation therapy for locally advanced pancreas cancer
Michael D. Chuong, Jonathan B. Ashman, Krishan R. Jethwa, et al.
International Journal of Radiation Oncology*Biology*Physics (2025)
Closed Access
Michael D. Chuong, Jonathan B. Ashman, Krishan R. Jethwa, et al.
International Journal of Radiation Oncology*Biology*Physics (2025)
Closed Access
Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer Patients
Eric W. Hewitt, Gauthier Bouche, Alexandre Alencar, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 429-440
Open Access
Eric W. Hewitt, Gauthier Bouche, Alexandre Alencar, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 429-440
Open Access
The Association of Aquaporins with MAPK Signaling Pathway Unveils Potential Prognostic Biomarkers for Pancreatic Cancer: A Transcriptomics Approach
Inês V. da Silva, Paula A. Lopes, Elisabete Fonseca, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 488-488
Open Access
Inês V. da Silva, Paula A. Lopes, Elisabete Fonseca, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 488-488
Open Access
Combined Omipalisib and MAPK Inhibition Suppress PDAC Growth
Bailey A. Bye, Jarrid Jack, Alexandra Pierce, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1152-1152
Open Access
Bailey A. Bye, Jarrid Jack, Alexandra Pierce, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1152-1152
Open Access
Correlation of MRI characteristics with KRAS mutation status in pancreatic ductal adenocarcinoma
Junjian Shen, Xingxing Wang, Kaifan Yu, et al.
Abdominal Radiology (2025)
Closed Access
Junjian Shen, Xingxing Wang, Kaifan Yu, et al.
Abdominal Radiology (2025)
Closed Access
Crosstalk between pancreatic cancer and adipose tissue: Molecular mechanisms and therapeutic implications
Babacar Diao, Zhiyao Fan, Bin Zhou, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 740, pp. 151012-151012
Closed Access | Times Cited: 3
Babacar Diao, Zhiyao Fan, Bin Zhou, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 740, pp. 151012-151012
Closed Access | Times Cited: 3
MRTX1133’s promise for treating KRASG12D-mutant pancreatic cancer
Malak Haidar, Patrick Jacquemin
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 4, pp. 2002-2005
Open Access | Times Cited: 1
Malak Haidar, Patrick Jacquemin
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 4, pp. 2002-2005
Open Access | Times Cited: 1
Fighting Pancreatic Cancer with a Vaccine-Based Winning Combination: Hope or Reality?
Silvia Brugiapaglia, Ferdinando Spagnolo, Simona Intonti, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1558-1558
Open Access | Times Cited: 1
Silvia Brugiapaglia, Ferdinando Spagnolo, Simona Intonti, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1558-1558
Open Access | Times Cited: 1
Targeting Non-histone Methylation in Gastrointestinal Cancers: From biology to clinic
Zhanbo Sun, Lixian Liu, Jun Chen
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116802-116802
Closed Access
Zhanbo Sun, Lixian Liu, Jun Chen
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116802-116802
Closed Access
Metastatic clear cell sarcoma of the pancreas: An overview
Rachid Ait Addi
World Journal of Clinical Cases (2024) Vol. 12, Iss. 29, pp. 6262-6265
Open Access
Rachid Ait Addi
World Journal of Clinical Cases (2024) Vol. 12, Iss. 29, pp. 6262-6265
Open Access
Ivermectin Combined With Recombinant Methioninase (rMETase) Synergistically Eradicates MiaPaCa-2 Pancreatic Cancer Cells
Sei Morinaga, Qinghong Han, KOHEI MIZUTA, et al.
Anticancer Research (2024) Vol. 45, Iss. 1, pp. 97-103
Closed Access
Sei Morinaga, Qinghong Han, KOHEI MIZUTA, et al.
Anticancer Research (2024) Vol. 45, Iss. 1, pp. 97-103
Closed Access
